Literature DB >> 2606576

Antigenic modulation and internalization of monoclonal antibody to human colonic carcinoma cells detected by enzyme-linked immunosorbent assay.

T Yokota1, E Otsuji, A Noguchi, T Yamaguchi, K Sawai, T Takahashi.   

Abstract

We studied antigenic modulation and internalization of monoclonal antibody (MAb) A7 using the enzyme-linked immunosorbent assay (ELISA) and biotin-labelled antibody-staining techniques. Incubation of the colonic SW1116 cell line with an excess of MAb A7 induced modulation of the cell-surface antigen. When the line was assayed by ELISA, a change in cellular reactivity with MAb A7 was seen after 1 hr. After 24 hr, the cellular reactivity showed a 52% decrease in absorbance. Modulation was inhibited by 0.1% sodium azide and acetone fixation, suggesting that this is an energy-dependent phenomenon. The internalization of biotinylated MAb A7 was examined. Internalized biotinylated MAb A7 was detected in cells fixed before labelling with avidin-biotin peroxidase complex. It was observed that the amount of MAb A7 which remained associated with the cell surface had decreased since A7 was internalized.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2606576     DOI: 10.1002/ijc.2910440626

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  Fate of antibody-neocarzinostatin conjugates bound to human colonic carcinoma cells in vitro.

Authors:  T Yokota; T Yamaguchi; K Kitamura; T Takahashi
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct

2.  A critical comparison of three internalization assays applied to the evaluation of a given mAb as a toxin-carrier candidate.

Authors:  P Casalini; M Caldera; S Canevari; S Ménard; D Mezzanzanica; E Tosi; M Gadina; M I Colnaghi
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

3.  Decreased renal accumulation of biotinylated chimeric monoclonal antibody-neocarzinostatin conjugate after administration of avidin.

Authors:  E Otsuji; T Yamaguchi; K Yamamoto; H Matsumura; H Tsuruta; Y Yata; H Nishi; K Okamoto; K Kitamura; T Takahashi
Journal:  Jpn J Cancer Res       Date:  1997-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.